The Dr. Holhoș network has inaugurated the largest private ophthalmology hospital in Transylvania, following an investment of approximately €6 million.
Romanian patients wait, on average, 460 days to access innovative medicines, even after these therapies have been approved for reimbursement by the National Agency for Medicines and Medical Devices (ANMDM).
7X Partners, a private equity investment company, has acquired a 40% stake in Leventer Medical Group, a centre for dermato-oncology based in Bucharest.
The agreement signifies a joint commitment to enhance healthcare infrastructure in Romania.
ING Bank Romania has financed Medisprof Group, which owns the largest private oncology hospital in western Romania, to expand in the region of Moldova.
Romania's national electricity transmission company Transelectrica is managing €51.7 million in funding from the National Recovery and Resilience Plan's (PNRR) REPowerEU component.
Synevo Romania has appointed Adrian Tudoscă as General Manager, while Laurențiu Luca takes over leadership of diagnostic operations across 11 Southeast European markets.
Romania's Ministry of Finance is conducting its fourth public offering of Fidelis government bonds this year, running from April 14 to 21 on the BVB. .
Romanian authorities are making sustained efforts to avoid downgrading the country's rating to 'junk' (speculative investments) category, which would hinder access to financial markets and increase borrowing costs for both the state and companies.
Oscar Downstream has appointed Silvia Ene as Chief Operating and Strategy Officer, a role designed to accelerate the company's strategic directions.